pretickt

UnitedHealth Group Incorporated (UNH)

Healthcare · end-of-day data as of Oct 16, 2026

UnitedHealth Group Incorporated
UNH · $360B
$401.43-4.0%last 60 sessions · close Oct 16, 2026
$255.97$433.6852 weeks
Buy · 26 analystsPT $460.17 +14.6%
  • P/E vs own-1.6%
  • P/E vs sector-18.6%
  • Target upside+14.6%
  • Off 52w high-7.4%
  • Insiders-$661K
  • FCF yield+6.3%
  • Earnings in96d
  • Trendbullish
  • Sector▲ +16.0%
  • RSI63
  • MA20×50↑ in ~8d
  • Volume1.4x
  • Support-0.9%
  • Resistance+2.7%

The average 12-month analyst price target for UNH is $460.17, 14.6% above the last close of $401.43 on Oct 16, 2026; targets range from $313.26 to $529.12. Rating consensus: Buy.

Snapshot

  • P/E22.9x
  • P/E vs sector-18.6%
  • P/E vs own-1.6%
  • Target upside+14.6%
  • ConsensusBuy
  • Market cap$360B
  • FCF yield+6.3%
  • Insiders-$661K
  • Earnings in96d
  • News

Why it moved

UnitedHealth Group Incorporated (UNH) fell 1.3% on Oct 16, 2026.

The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.

Market (SPY)-1.1%
Healthcare sector+0.4%
UNH specific-0.6%

6 stories on the day (30-day average 3.7).

Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.

Price and events

⇔⇕$268$319$371$422Oct 25Jan 26Apr 26Jul 26Oct 26EDEDAEAADAEDE

Last close $401.43 · +15.5% over 1y · E earnings · D dividend · S split · A analyst rating change

Technicals

  • Trendbullish
  • Sector▲ +16.0%
  • MAs20▲ 50▲ 100▲ 200▲
  • Above MAs4 of 4 above
  • MA20×50↑ in ~8d
  • RSI63
  • Support-0.9%
  • Resistance+2.7%
  • Off 52w high-7.4%
  • Off ATH-32.7%
  • 52w range$401.43
  • Bollingerabove upper
  • MACD4.22
  • ATR+3.0%
  • Volume1.4x

Analyst price targets

Low$313.26
Average$460.17
Median$476.28
High$529.12
Upside+14.6%

24 firms with a target in the last 12 months · last close $401.43 · as of Oct 16, 2026

⇔⇕$242$317$393$468$543Oct 25Mar 26Aug 26Jan 27Jun 270%-22%-5%+16%+17%+31%
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets

Strong buy 7 · Buy 15 · Hold 4 · Sell 0 · Strong sell 0

Revenue and free cash flow

Q3 FY2026: Revenue -0.4% year over year, free cash flow 3.8% of revenue, operating margin 5.8%.

RevenueFree cash flow
Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Q3 FY2026Sep 30, 2026$113B4.56$4.26B100.0%5.8%3.6%
Q2 FY2026Jun 30, 2026$112B6.05$10.25B32.7%7.1%4.9%
Q1 FY2026Mar 31, 2026$112B6.90$8.15B22.7%8.0%5.6%
Q4 FY2025Dec 31, 2025$113B0.01$160M16.3%0.3%0.0%
Q3 FY2025Sep 30, 2025$113B2.59$5.05B18.2%3.8%2.1%
Q2 FY2025Jun 30, 2025$112B3.74$6.3B17.9%4.6%3.1%
Q1 FY2025Mar 31, 2025$110B6.85$4.56B21.7%8.3%5.7%
Q4 FY2024Dec 31, 2024$101B5.98$1.46B21.1%7.7%5.5%

Peers

20D
1ABBVAbbVie Inc.$285.42+0.7%0.0%-1.4%80.4$504B
2UNHUnitedHealth Group Incorporated$401.43-1.3%-7.4%+14.6%22.9$360B
3MRKMerck & Co., Inc.$145.95+0.5%-6.2%+7.7%116.8$360B
4CVSCVS Health Corp.$92.36-0.2%-16.0%+20.9%24.4$118B
5ELVElevance Health Inc.$428.260.0%0.0%+1.9%19.0$92.88B
6CICigna Corporation$302.30+1.2%-0.2%+10.9%12.5$79.88B
7HUMHumana Inc.$413.16-4.4%-4.7%+15.7%39.1$49.63B
8CNCCentene Corp.$69.16-1.9%-1.9%-0.5%—$34.16B

Data as of Oct 16, 2026 close.

Latest news

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.